MARKET WIRE NEWS
  1. Home
  2. Stock
  3. RLMD
  4. News
RLMD
Quote
Short
News
Articles
Message Board

Relmada Therapeutics Inc. (NASDAQ : RLMD ) News

News Releases

RLMD News Releases
RLMD : NASDAQ
SeekingAlpha
Relmada: NDV-01 Entering Phase 3 In NMIBC, But There's No Rush To Buy Stock Today
RLMD : NASDAQ
GlobeNewswire
Relmada Therapeutics Appoints CNS Drug Development Veteran Michael Quirk as Senior Advisor for Sepranolone Program
RLMD : NASDAQ
GlobeNewswire
Relmada Therapeutics to Present at the Jefferies Global Healthcare Conference
RLMD : NASDAQ
SeekingAlpha
Relmada targets mid-2026 Phase 3 RESCUE start backed by $234M cash runway through 2029
RLMD : NASDAQ
SeekingAlpha
Relmada Therapeutics, Inc. (RLMD) Q1 2026 Earnings Call Transcript
RLMD : NASDAQ
SeekingAlpha
Relmada Therapeutics GAAP EPS of -$0.22 misses by $0.02
RLMD : NASDAQ
GlobeNewswire
Relmada Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Update
RLMD : NASDAQ
GlobeNewswire
Relmada Therapeutics to Report First Quarter 2026 Financial Results on Tuesday, May 12, 2026
RLMD : NASDAQ
GlobeNewswire
Relmada Therapeutics to Present NDV-01 Abstracts at AUA2026
RLMD : NASDAQ
IBN Spotlights
Relmada Therapeutics Inc. (NASDAQ: RLMD) is a Stock Spotlight on 4/24
Next 10

Subscribe to Our Newsletter

Get Instant Newsletter Alerts to your Mobile Device and Email as soon as the News or Alerts hit the wire.

Download The Market Wire News App

Get instant news alerts to your mobile device as soon as the news hits the wire. Simply add a stock symbol to your portfolio and our service will alert you anytime there is news.

Market Wire News iPhone App Market Wire News Android App

Link Market Wire News to Your X Account

Link your X account with Market Wire News to automatically tweet trending stocks news and your portfolio stocks news.